SIRT1 and diabetes mellitus: A GLP-1 receptor agonist called ligarglutide (LIR) controls blood sugar levels and reduces vascular stress to help manage diabetes, while also preventing diabetic CVDs by targeting high-glucose induced endothelial cell senescence via the SIRT1-p53/65 signaling pathway (Zhong et al., 2025).